Tirzepatide has a half-life of about 5 days, meaning roughly half of the medication is still present after that time
PlexusDx offers the Precision Peptide Genetic Test, which identifies individual variations in GIPR, FTO, and MC4R genesgenetic markers that help clarify whether someone's body physiology actually responds to GLP-1 signaling in ways that would benefit from medication
This review focuses principally on GLP-1 RAs approved for treating both T2DM and obesity: liraglutide, semaglutide, and tirzepatide
Some research indicates that these drugs may help protect joints and reduce bone erosion, potentially preserving mobility and quality of life
Side effects The most common side effects include nausea, vomiting, and diarrhea, necessitating a slow titration of the dose to ensure tolerance
Semaglutide is most often given as a shot in the stomach area once every week